JPH0569466B2 - - Google Patents
Info
- Publication number
- JPH0569466B2 JPH0569466B2 JP62080470A JP8047087A JPH0569466B2 JP H0569466 B2 JPH0569466 B2 JP H0569466B2 JP 62080470 A JP62080470 A JP 62080470A JP 8047087 A JP8047087 A JP 8047087A JP H0569466 B2 JPH0569466 B2 JP H0569466B2
- Authority
- JP
- Japan
- Prior art keywords
- hemoglobin
- feces
- sample
- lytic enzyme
- lysozyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Description
【発明の詳細な説明】
イ 発明の目的
(a) 産業上の利用分野
この発明は糞便中のヘモグロビンの検出方法に
関するものである。Detailed Description of the Invention A. Object of the Invention (a) Field of Industrial Application This invention relates to a method for detecting hemoglobin in feces.
(b) 従来技術
消化器系統の異常、例えば癌、潰瘍等を早期に
発見する検診方法として糞便中に混じた血液の代
表的蛋白質であるヘモグロビンを検出するのが普
通に行われる。この糞便中のヘモグロビンの検出
には従来からベンチジン法等の化学的糞便潜血反
応法や免疫学的方法による検出が行われている。(b) Prior Art As a screening method for early detection of abnormalities in the digestive system, such as cancer and ulcers, it is common to detect hemoglobin, a typical protein in blood mixed in feces. Conventionally, hemoglobin in feces has been detected by a chemical fecal occult blood reaction method such as the benzidine method or by an immunological method.
一般に化学的反応法は非常に敏感であつて偽陽
性が多くでる欠点があり、叉同法では血液中のヘ
モグロビンのペルオキシダーゼ活性を検出するが
ペルオキシダーゼ活性は肉、野菜等にも存在する
ので検査前に食餌を制限する必要がある。 In general, chemical reaction methods have the disadvantage of being very sensitive and producing many false positives.Although the chemical reaction method detects the peroxidase activity of hemoglobin in the blood, peroxidase activity is also present in meat, vegetables, etc. It is necessary to restrict food intake.
また消化酵素で分解されたヘモグロビンも検出
するので全消化器径路での出血を検出してしまい
出血部位の情報が得られず、例えば大腸癌等の消
化器系統下部からの出血を証明することができな
い欠点があり、単独の方法としては用いられてい
ない。 It also detects hemoglobin that has been broken down by digestive enzymes, so it detects bleeding in the entire digestive system, making it impossible to obtain information on the site of bleeding, making it difficult to prove bleeding from the lower part of the digestive system, such as in cases of colon cancer. It has the drawback that it cannot be used as a stand-alone method.
これに対し最近Barrow(Am.J.Cli.Pathol.69:
342,1978 March)らを始めとしてヒトヘモグ
ロビンと抗ヒトヘモグロビンの抗体−抗原反応を
用いる免疫学的糞便潜血反応による測定法が開発
されている。この免疫学的糞便潜血測定法による
と、ヘモグロビンは消化系統中での消化酵素の作
用を受けると大部分の抗原性を失うので、ヒトヘ
モグロビンに対する特異性は勿論糞便中で抗原性
を残す消化器系統の下部からの出血のみを検出す
ることができる特徴を有するものである。この方
法には、例えば特開昭61−137064号にあるように
濾紙に糞便を塗布しヒトヘモグロビン抗体を感作
した担体粒子と混合し、該混合物での担体粒子の
凝集状態を判定する方法や特願昭60−069598号の
にあるように糞便を疎水性樹脂に接触させてヘモ
グロビンを吸着させ、これに酵素標識抗体試薬に
より抗原抗体反応を生ぜしめて基質液に浸して呈
色度により検出する方法等が公知である。 In contrast, recently Barrow (Am.J.Cli.Pathol.69:
342, March 1978) have developed an immunological measurement method based on fecal occult blood reaction using an antibody-antigen reaction between human hemoglobin and anti-human hemoglobin. According to this immunological fecal occult blood measurement method, hemoglobin loses most of its antigenicity when subjected to the action of digestive enzymes in the digestive system. It has the characteristic of being able to detect only bleeding from the lower part of the system. This method includes, for example, a method in which feces is applied to a filter paper and mixed with carrier particles sensitized with human hemoglobin antibodies, as described in JP-A-61-137064, and the state of aggregation of the carrier particles in the mixture is determined. As described in Japanese Patent Application No. 60-069598, feces is brought into contact with a hydrophobic resin to adsorb hemoglobin, an antigen-antibody reaction is generated using an enzyme-labeled antibody reagent, and the feces is immersed in a substrate solution to be detected by coloration. Methods and the like are publicly known.
(c) 発明が解決しようとする問題点
一般にヘモグロビンは抗体に対する力価が弱い
ので免疫学的測定での測定感度が低く不利であ
り、且つ消化酵素や腸内細菌の産出する蛋白分解
酵素の作用によつて構造変化をきたし易く免疫学
的検出に不利である。特に糞便中のヘモグロビン
を免疫学的反応法で検出する場合、
(a) ヘモグロビンが消化管から分泌される粘液成
分や腸内細菌の細胞壁成分と結合して免疫学的
反応性が低下する
(b) 糞便中のヘモグロビンは腸内細菌によつて分
解され易く、分解されて時間の経過と共に減少
する
ので検出が不安定になるという問題点がある。(c) Problems to be solved by the invention In general, hemoglobin has a weak titer against antibodies, so the sensitivity of immunoassays is low and disadvantageous, and the action of digestive enzymes and proteolytic enzymes produced by intestinal bacteria is disadvantageous. It is disadvantageous for immunological detection because it easily undergoes structural changes due to In particular, when detecting hemoglobin in feces using an immunological reaction method, (a) hemoglobin binds to mucus components secreted from the gastrointestinal tract and cell wall components of intestinal bacteria, reducing immunological reactivity (b) ) Hemoglobin in feces is easily decomposed by intestinal bacteria, and as it decomposes and decreases over time, there is a problem that detection becomes unstable.
ロ 発明の構成
(a) 問題点を解決するための手段
本発明は採取した糞便にグリコシダーゼ型細胞
壁溶解酵素(以下溶菌酵素という)を添加もしく
は作用せしめて免疫学的方法によつて糞便中のヘ
モグロビンを検出する方法であり従来法の欠点を
解消するものである。B. Structure of the Invention (a) Means for Solving the Problems The present invention involves adding or allowing glycosidase-type cell wall lytic enzymes (hereinafter referred to as bacteriolytic enzymes) to act on collected feces to determine the amount of hemoglobin in the feces by an immunological method. This method eliminates the drawbacks of conventional methods.
グリコシダーゼ型溶菌酵素、例えばリゾチーム
を食品、医薬等の防腐剤として用いることは公知
であるが、これを糞便中に混入すると長時間での
腸内細菌によるヘモグロビンの分解を防止する効
果がある。(前記欠点(b))
本発明者は種々実験の結果、グリコシダーゼ型
溶菌酵素は前記の防腐効果(腸内細菌による分解
を防止する効果)以外に糞便中の粘液成分や腸内
細菌の細胞壁成分に結合しているヘモグロビンの
結合を短時間で遊離させて免疫学的反応性を回復
させる効果も有することを発見して本発明をなし
たものである。 The use of glycosidase-type bacteriolytic enzymes, such as lysozyme, as preservatives for foods, medicines, etc. is known, and when mixed into feces, it has the effect of preventing the decomposition of hemoglobin by intestinal bacteria over a long period of time. (Disadvantage (b) above) As a result of various experiments, the present inventor found that glycosidase-type bacteriolytic enzymes have an antiseptic effect (preventing decomposition by intestinal bacteria), as well as mucus components in feces and cell wall components of intestinal bacteria. The present invention was made based on the discovery that it also has the effect of restoring immunological reactivity by releasing hemoglobin binding in a short period of time.
(b) 作用
前記のように糞便中のヘモグロビンは糞便中の
粘液成分と細菌の細胞壁成分と結合しており、し
かも時間の経過と共に細菌によつて分解されて減
少するが、グリコシダーゼ型溶菌酵素、例えばリ
ゾチーム、を添加して免疫学的方法によつてヘモ
グロビンを検出するとヘモグロビンが短時間で粘
液成分や細胞壁成分から遊離して完全に検出で
き、しかも試料を長時間保管しても正しい検出結
果が得られる。(b) Action As mentioned above, hemoglobin in feces is bound to mucus components in feces and bacterial cell wall components, and is degraded by bacteria over time and decreases. For example, when hemoglobin is detected using an immunological method with the addition of lysozyme, the hemoglobin is released from mucus and cell wall components in a short period of time and can be completely detected, and accurate detection results can be obtained even if the sample is stored for a long time. can get.
この場合に溶菌酵素としてはグリコシダーゼ型
溶菌酵素であれば良いが、リゾチームが一般に市
販されており使用し易い。 In this case, the lytic enzyme may be any glycosidase-type lytic enzyme, but lysozyme is generally commercially available and easy to use.
添加は単に溶菌酵素の溶液に採取した糞便を浸
すかあるいは糞便を溶解してもよい。また溶菌酵
素を含有させた寒天ゲル容器中に糞便の試料を差
し込み吸収させる方法や溶菌酵素を含ませた濾紙
に糞便を塗りつける方法等各種の方法で作用さし
ても良い。 The addition may be done by simply soaking the collected feces in a solution of the lytic enzyme or by dissolving the feces. Alternatively, various methods may be used, such as a method in which a fecal sample is inserted into an agar gel container containing a lytic enzyme and absorbed, or a method in which fecal matter is smeared onto a filter paper containing a lytic enzyme.
また検出方法としては普通の免疫学的測定方法
を用いればよい。 Further, as a detection method, a common immunoassay method may be used.
例えば、プラスチツク製の先端に溝をもうけた
採便サジを抗ヒトヘモグロビン抗体を含むトリス
緩衝液に一昼夜浸漬してコーテイングして、この
サジを糞便中の異なつた場所に数回突きさして、
トイレツトペーパーで余剰の糞便を拭きとり溝の
部分に一定量の糞便を採取する。一方市販のアガ
ロース(寒天)を2%になるように食塩加リン酸
緩衝液に加え、加熱溶解し約60℃の温度に下げた
状態での寒天溶液に溶菌酵素(リゾチーム)を1
ml当たり3mg,NaN3を終濃度0.1%になるように
加えて寒天ゲル容器に分注して冷却しゲル化し溶
菌酵素を含む寒天を造る。その寒天ゲル中に前記
糞便を採取した採便サジを差し込み一定時間放置
する。そうすると糞便中のヘモグロビンは寒天ゲ
ル中に拡散するが、その時溶菌酵素の作用によつ
て粘液成分や細胞壁成分と結合しているヘモグロ
ビンが遊離されて採便サジのコーテイングされた
抗ヒトヘモグロビン抗体と結合して採便サジの表
面に完全に補足される。この状態では溶菌酵素と
NaN3の防腐作用によつて腸内細菌によるヘモグ
ロビンの分解も阻止されている。この採便サジを
取り出して洗浄し、公知(例えば吉武氏らの免疫
実験法XI,P.3497〜3519,1982)の方法で調整
したアルカリフオスフアターゼ標識抗体に浸漬し
て抗原抗体反応を行わせる。次いで採便サジを洗
浄した後、アルカリフオスフアターゼをKind−
King法で測定する。すなわちフエニル燐酸基質
液を入れた小試験管に採便サジを入れて37℃、30
分間インキユベートして呈色液を加えて反応を停
止させ、呈色度を測定すれば良い。このようにす
ると糞便中のヘモグロビンが完全に採便サジの抗
体に補足されて精度良くヘモグロビンを検出する
ことができる。 For example, a plastic stool sample with a grooved tip is coated by soaking it in Tris buffer containing anti-human hemoglobin antibody overnight, and this sample is inserted several times into different locations in the feces.
Wipe off excess feces with toilet paper and collect a certain amount of feces in the groove. On the other hand, add commercially available agarose (agar) to a concentration of 2% in a phosphate buffer solution containing sodium chloride, dissolve it by heating, and lower the temperature to about 60°C. Add 1 lytic enzyme (lysozyme) to the agar solution.
Add 3 mg of NaN 3 per ml to a final concentration of 0.1%, dispense into an agar gel container, and cool to gel to create agar containing the lytic enzyme. The stool collection tube containing the feces is inserted into the agar gel and left for a certain period of time. Then, the hemoglobin in the feces diffuses into the agar gel, and at this time, the hemoglobin bound to mucus and cell wall components is released by the action of the lytic enzyme and binds to the anti-human hemoglobin antibody coated on the stool sample. It is completely captured on the surface of the feces sample. In this state, the lytic enzyme
The preservative effect of NaN 3 also prevents hemoglobin from being degraded by intestinal bacteria. This stool sample is taken out, washed, and immersed in an alkaline phosphatase-labeled antibody prepared using a known method (for example, Yoshitake et al., Immunology Experimental Methods XI, pp. 3497-3519, 1982) to perform an antigen-antibody reaction. let Next, after washing the stool sample, alkaline phosphatase was added to Kind-
Measure using the King method. In other words, place a stool sample into a small test tube containing phenylphosphate substrate solution and incubate at 37℃ for 30 minutes.
After incubating for a minute, a coloring solution is added to stop the reaction, and the degree of coloring can be measured. In this way, the hemoglobin in the feces is completely captured by the antibodies of the feces sample, making it possible to detect hemoglobin with high accuracy.
或いは前記溶菌酵素(リゾチーム)とNaN3を
溶解した液は厚手の染み込ませた濾紙に糞便をヘ
ラで薄く塗りつけて試料としてもよく、また溶液
に細棒で採取した糞便を溶解して試料としてもよ
いことは勿論である。 Alternatively, the solution in which the lytic enzyme (lysozyme) and NaN 3 are dissolved may be used as a sample by applying a thin layer of feces on a thick impregnated filter paper with a spatula, or as a sample by dissolving feces collected with a thin stick in the solution. Of course it's a good thing.
(c) 実施例
実施例 1
多数(129人)の糞便の試料につき、そのまま
の試料とリゾチームを添加した場合のヘモグロビ
ンをELISA法(Enzyme−Linked
Immunosorbent Assay)によつて測定した。(c) Examples Example 1 Using the ELISA method (Enzyme-Linked
Measured by Immunosorbent Assay).
細棒により糞便を少量採取したものを食塩加リ
ン酸緩衝液(PH7.2,0.1M)に1ml当たりNaN3
を1mg加えた緩衝液と該緩衝液に溶菌酵素として
リゾチームを1ml中に4mg加えた緩衝液を1ml入
れた小壜中に浸漬して溶解した。 Collect a small amount of feces with a thin stick and add NaN 3 per ml to saline phosphate buffer (PH7.2, 0.1M).
The cells were immersed in a small bottle containing 1 ml of a buffer containing 1 mg of lysozyme and 4 mg of lysozyme as a lytic enzyme per 1 ml of the buffer.
ELISA用マイクロプレートの各穴に抗ヒトヘ
モグロビン抗体(市販DAKO社製)を終濃度で
200倍希釈の割合で含むトリス緩衝液(PH8.4,
0.05M)を100μづつ分注して4〜8℃で12時間
放置してコーテイングする。 Add anti-human hemoglobin antibody (commercially available from DAKO) to each well of the ELISA microplate at the final concentration.
Tris buffer (PH8.4,
0.05M) was dispensed in 100μ portions and left at 4-8°C for 12 hours for coating.
抗体をコーテイングしたプレートを脱イオン水
で洗浄後、各穴に1%牛アルブミンを含む食塩加
リン酸緩衝液を100μづつ分注する。これに前
記の糞便の汁(便汁)を50μ注入し、37℃で60
分間、抗原抗体反応をさせる。 After washing the antibody-coated plate with deionized water, dispense 100 μl of saline phosphate buffer containing 1% bovine albumin into each well. Inject 50μ of the fecal juice (fecal juice) mentioned above into this, and heat it for 60 minutes at 37°C.
Allow antigen-antibody reaction to occur for 1 minute.
次いで良く洗浄後アルカリフオスフアターゼ標
識抗体試薬を100μづつ各穴に分注し、37℃、
60分間抗原抗体反応をさせ、脱イオン水で洗浄
後、アルカリフオスフアターゼ測定用基質液を
100μづつ各穴に分注して37℃,30分間反応後
直ちに呈色試薬を100μ加えて反応を停止させ
る。各穴の呈色液をマイクロプレート用光度計で
側光した。 After washing well, dispense 100μ of alkaline phosphatase-labeled antibody reagent into each well and incubate at 37°C.
After allowing antigen-antibody reaction for 60 minutes and washing with deionized water, add substrate solution for alkaline phosphatase measurement.
Dispense 100 μl into each well and react at 37°C for 30 minutes, then immediately add 100 μl of coloring reagent to stop the reaction. The colored liquid in each well was side-illuminated using a microplate photometer.
その結果を無添加の試料の呈色度を横軸にリゾ
チーム添加試料の呈色を縦軸にプロツトしたとこ
ろ第1図のようになつた。 When the results were plotted, the degree of coloration of the sample without additives was plotted on the horizontal axis and the coloration of the lysozyme-added sample was plotted on the vertical axis, and the result was as shown in FIG.
リゾチームを添加した試料の測定値は添加しな
い測定値より大で(45度の線より上にある)あ
り、ヘモグロビンが完全に測定できていることが
分かる。通常上記のような検出においては吸光度
が100〜200を限界として判別しているが、かなり
の試料が無添加では陰性であるが、添加すると陽
性となり検出の精度が上昇していることが分かつ
た。 The measured value of the sample to which lysozyme was added was larger than the measured value without the addition (above the 45 degree line), indicating that hemoglobin was completely measured. Normally, in the above-mentioned detection, the absorbance is determined as a limit of 100 to 200, but it was found that a considerable number of samples were negative without the additive, but became positive with the addition, increasing the accuracy of detection. .
実施例 2
健常者30人の便汁を混合して造つた約25%便汁
に全血を終濃度10000倍の割合で添加してヘモグ
ロビンの量の時間的変化を調査した。結果は第2
図の通りであつた。Example 2 Whole blood was added at a final concentration of 10,000 times to approximately 25% stool juice prepared by mixing the stool juices of 30 healthy subjects, and the temporal change in the amount of hemoglobin was investigated. The result is second
It was as shown in the picture.
これによりリゾチームを添加した便汁ではヘモ
グロビンの腸内細菌による分解の進行が阻止され
ていることが分かる。 This indicates that the progress of decomposition of hemoglobin by intestinal bacteria is inhibited in stool juice to which lysozyme has been added.
ハ 発明の効果
以上に詳しく説明したように、本発明は従来の
糞便の免疫学的ヘモグロビンの検出方法に対し、
単に被検者の糞便に溶菌酵素を添加するだけの処
理を追加するだけで、粘液成分や腸内細菌壁成分
と結合しているヘモグロビンを分離して正確な検
出ができるものであり、さらに検出作業前の試料
を長時間保存しても正しい検出ができる非常に有
効な糞便中のヘモグロビンの検出方法である。C. Effects of the Invention As explained in detail above, the present invention has advantages over the conventional method for immunologically detecting hemoglobin in feces.
By simply adding a lytic enzyme to the test subject's feces, hemoglobin bound to mucus components and intestinal bacterial wall components can be separated and accurately detected. This is a very effective method for detecting hemoglobin in feces, which allows accurate detection even if the sample is stored for a long time.
第1図は同じ糞便に溶菌酵素を添加した場合と
無添加の場合のヘモグロビンの測定結果を比較し
たグラフであり、第2図は糞便中のヘモグロビン
の量の時間的変化を比較した結果を示すグラフで
ある。
Figure 1 is a graph comparing the hemoglobin measurement results when lytic enzyme was added to the same stool and when it was not added. Figure 2 shows the results of comparing the temporal changes in the amount of hemoglobin in the stool. It is a graph.
Claims (1)
て、採取した糞便にグリコシダーゼ型溶菌酵素を
添加もしくは作用せしめて免疫学的測定法により
ヘモグロビンを検出することを特徴とする糞便中
のヘモグロビンの検出方法 2 グリコシダーゼ型溶菌酵素としてリゾチーム
を用いることを特徴とする特許請求の範囲第1項
記載の糞便中のヘモグロビンの検出方法 3 採便サジに抗ヒトヘモグロビン抗体をコーテ
イングして採便し、該試料を溶菌酵素を含むゲル
中に差し込んで一定時間試料を保存したのち免疫
学的測定法によりヘモグロビンを検出することを
特徴とする特許請求の範囲第1項あるいは第2項
記載の糞便中のヘモグロビンの検出方法。[Scope of Claims] 1. A method for detecting hemoglobin in feces, which comprises adding or allowing a glycosidase-type lytic enzyme to act on collected feces and detecting hemoglobin by an immunoassay method. Detection method 2 Method for detecting hemoglobin in feces according to claim 1, characterized in that lysozyme is used as a glycosidase-type bacteriolytic enzyme. The method according to claim 1 or 2, wherein the sample is inserted into a gel containing a lytic enzyme, the sample is preserved for a certain period of time, and then hemoglobin is detected by immunoassay. How to detect hemoglobin.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8047087A JPS63246667A (en) | 1987-03-31 | 1987-03-31 | Detection of hemoglobin in excrement |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8047087A JPS63246667A (en) | 1987-03-31 | 1987-03-31 | Detection of hemoglobin in excrement |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS63246667A JPS63246667A (en) | 1988-10-13 |
| JPH0569466B2 true JPH0569466B2 (en) | 1993-10-01 |
Family
ID=13719148
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP8047087A Granted JPS63246667A (en) | 1987-03-31 | 1987-03-31 | Detection of hemoglobin in excrement |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS63246667A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019107414A1 (en) | 2017-12-01 | 2019-06-06 | 栄研化学株式会社 | Method for stabilizing complex of hemoglobin and haptoglobin and a preservation solution for preserving specimens containing hemoglobin |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0259466U (en) * | 1988-10-20 | 1990-05-01 | ||
| JPH0260870U (en) * | 1988-10-26 | 1990-05-07 | ||
| SG11202008338PA (en) | 2018-03-02 | 2020-09-29 | Eiken Chemical | Method of stabilizing protein contained in specimen and solution for stabilizing protein contained in specimen |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS605900B2 (en) * | 1976-04-13 | 1985-02-14 | 中外製薬株式会社 | Quantification method for antigenic substances |
| DE2729555C2 (en) * | 1976-07-06 | 1985-12-12 | Becton, Dickinson and Co., East Rutherford, N.J. | Process for forming a coating of a receptor on a plastic substrate, the product obtained therefrom and its use |
| FI61965C (en) * | 1980-01-17 | 1982-10-11 | Suovaniemi Finnpipette | DETECTING OF HEMOGLOBIN AND DETECTION |
| EP0070366B1 (en) * | 1981-07-16 | 1985-08-28 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Method for the detection of human occult blood in human stool samples |
| JPS59125064A (en) * | 1983-01-05 | 1984-07-19 | Eiken Kagaku Kk | Method for detecting hemoglobin in fece using immunological latex clotting reaction and reagent to be used for said method |
| AU529210B3 (en) * | 1983-02-02 | 1983-04-14 | Australian Monoclonal Development Pty. Ltd. | Monoclonal antibody in occult blood diagnosis |
| JPS61228351A (en) * | 1985-04-02 | 1986-10-11 | Kyoto Ikagaku Kenkyusho:Kk | Method for detecting hemoglobin in excretion |
| JPH0612994B2 (en) * | 1985-09-13 | 1994-02-23 | ティーディーケイ株式会社 | Bioactive substance-immobilized magnetic particles |
-
1987
- 1987-03-31 JP JP8047087A patent/JPS63246667A/en active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019107414A1 (en) | 2017-12-01 | 2019-06-06 | 栄研化学株式会社 | Method for stabilizing complex of hemoglobin and haptoglobin and a preservation solution for preserving specimens containing hemoglobin |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS63246667A (en) | 1988-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0684970B2 (en) | Method of detecting occult blood in feces | |
| JP3551678B2 (en) | Method and kit for measuring hemoglobin A1c | |
| JPS61247965A (en) | Enzyme immunological measurement method | |
| JPH04501760A (en) | Apparatus and method for rapidly qualitatively or quantitatively measuring reactive ligands in fluids | |
| EP0189389B1 (en) | Immunoassay method for antibodies of different classes in a liquid sample | |
| EP0840126B1 (en) | Marker and immunological reagent for dialysis-related amyloidosis, diabetes mellitus and diabetes mellitus complications | |
| US5552292A (en) | Method of screening for colorectal cancer | |
| JPH0564737B2 (en) | ||
| Gebhard et al. | Dermatitis Herpetiformis IMMUNOLOGIC CONCOMITANTS OF SMALL INTESTINAL DISEASE AND RELATIONSHIP TO HISTOCOMPATIBILITY ANTIGEN HL-A8 | |
| Lindberg et al. | Serum IgA and IgG gliadin antibodies and small intestinal mucosal damage in children | |
| JPH0569466B2 (en) | ||
| EP0770875B1 (en) | Marker and reagent for diabetes mellitus and diabetes mellitus complication | |
| JP4274693B2 (en) | Crohn's disease test method and test kit | |
| JP2004012434A (en) | Method for measuring pepsinogen and measuring kit | |
| JPS63246668A (en) | Detection of occult blood in excrement | |
| EP0348144B1 (en) | Method for treating mucus-containing immunoassay samples | |
| JPS628055A (en) | Enzymatic immunoassay | |
| CA1193192A (en) | Method of determinination of human urine kallikrein and kit for the same | |
| JP2534067B2 (en) | Quantitative method for C-reactive protein | |
| RU2251697C1 (en) | Method for detecting functional activity of human complement c3 component according to classical way of activation | |
| JP2747643B2 (en) | Colorectal cancer screening method and kit therefor | |
| RU2147130C1 (en) | Method for evaluating blood losses from the gastroenteric tract | |
| Ludlam et al. | Plasminogen assay by a haemagglutination inhibition technique | |
| JPH09178752A (en) | Microbial detection method and detection test set | |
| RU2143699C1 (en) | Method for diagnosing restricted forms of pulmonary tuberculosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |